GE appoints Denman as CMO

William Denman, MD, has been appointed chief medical officer (CMO) at GE Healthcare.

Denman is the former chief medical officer and vice president of medical affairs for Covidien, based in Dublin, where he was responsible for strategic direction of medical affairs, clinical affairs and healthcare economics and outcomes, according to GE.

At GE, the company said that Denman will provide clinical direction, working with the global quality, regulatory and medical organizations. Denman also will lead all clinical and evidence generation strategies across GE Healthcare.  Denman will be part of GE's newly expanded global quality, regulatory and medical organization, led by Chief Quality Officer Dee Mellor.

Denman is currently involved in various clinical and basic science research projects at Massachusetts General Hospital and Harvard Medical School in Boston. He received his Doctor of Medicine at the University of Aberdeen in Scotland.

 

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”